We are live on ! Find out more
STAA icon

STAAR Surgical

201 hedge funds and large institutions have $1.21B invested in STAAR Surgical in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 70 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 40

2.78% more ownership

Funds ownership: 102.52%105.3% (+2.8%)

3% more funds holding

Funds holding: 196201 (+5)

11% less capital invested

Capital invested by funds: $1.36B → $1.21B (-$150M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

27% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 70

61% less call options, than puts

Call options by funds: $11.2M | Put options by funds: $28.8M

Holders
201
Holders Change
+5
Holders Change %
+2.55%
% of All Funds
2.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
46
Increased
51
Reduced
70
Closed
40
Calls
$11.2M
Puts
$28.8M
Net Calls
-$17.6M
Net Calls Change
-$10M

STAA Hedge Fund Activity: Q4 2025 in Review

201 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2025, worth a combined $1.21B — down 11% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new STAA positions and 40 closed out — a net gain of 6 holders — while 51 added to existing stakes and 70 trimmed.

The largest buyer was Broadwood Capital, adding an estimated $38.7M. The largest seller was Sand Grove Capital Management, exiting entirely with an estimated $22.3M sold.

  • 201 institutional investors held STAAR Surgical (STAA) as of Q4 2025, up from 196 in Q3 2025.
  • Funds reported $1.21B of STAAR Surgical stock for Q4 2025, down 11% quarter-over-quarter.
  • 46 funds opened new STAAR Surgical positions in Q4 2025 and 40 closed out, a net change of +6 holders.
  • The largest STAAR Surgical buyer in Q4 2025 was Broadwood Capital, an estimated $38.7M added.
  • The largest STAAR Surgical seller in Q4 2025 was Sand Grove Capital Management, an estimated $22.3M sold.

Based on aggregated 13F filings for Q4 2025.